The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I study of ABT-199 (GDC-0199) in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL): Responses observed in diffuse large B-cell (DLBCL) and follicular lymphoma (FL) at higher cohort doses.
Matthew Steven Davids
No relevant relationships to disclose
John Francis Seymour
Consultant or Advisory Role - AbbVie; Roche/Genentech
Research Funding - AbbVie; Genentech
John F. Gerecitano
Research Funding - AbbVie; Genentech
Brad S. Kahl
Consultant or Advisory Role - Genentech
Research Funding - AbbVie; Genentech
John M. Pagel
No relevant relationships to disclose
William G. Wierda
Consultant or Advisory Role - Roche/Genentech
Research Funding - AbbVie; Genentech
Mary Ann Anderson
Research Funding - AbbVie; Genentech
Nikita Rudersdorf
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Lori A. Gressick
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Nicholas P. Montalvo
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Jianning Yang
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Ming Zhu
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Martin Dunbar
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Elisa Cerri
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Sari H. Enschede
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Rod Humerickhouse
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Andrew Warwick Roberts
Research Funding - AbbVie; Genentech